COMMUNIQUÉS West-GlobeNewswire

-
PhotoniCare's OtoSight Demonstrates More Accurate Diagnosis and a 50 Percent Reduction in Antibiotic Usage for Pediatric Ear Infections in Large Randomized Controlled Trial
19/05/2025 -
The Developing Doctor Launches New Online Course to Empower Early-Career Physicians
19/05/2025 -
BeeCure Celebrates World Bee Day
19/05/2025 -
Healthcare Consulting & Contracting (HC3) Founder and Senior Toxicologist Dr. J. David Krause Honored with AIHA’s 2024 Lila Albin Best IEQ Paper Award
19/05/2025 -
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
19/05/2025 -
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
19/05/2025 -
Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue
19/05/2025 -
Transactions in Connection with Share Buy-back Program
19/05/2025 -
Hospice Choices: VITAS® Healthcare Is Now Serving Marion County, Florida
19/05/2025 -
vTv Therapeutics Appoints Michael Tung, M.D., MBA, to Chief Financial Officer as Company Reinitiates Phase 3 Trial of Oral T1D Adjunctive Therapy to Insulin
19/05/2025 -
GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals
19/05/2025 -
Arbor Biotechnologies Appoints Don Haut, Ph.D., as Chief Business Officer
19/05/2025 -
Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer
19/05/2025 -
Porch Light Health Partners with CHESS Health to Offer a Contingency Management Incentives Program to Boost SUD Treatment Outcomes
19/05/2025 -
MEDIROM Healthcare Technologies Inc. to Host Webcast on May 21, 2025 at 8:30 AM ET to Discuss 2024 Financial Results
19/05/2025 -
Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition
19/05/2025 -
Phase II Data in Treatment-Naïve Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients: Ruxoprubart Demonstrates Best-in-Class Efficacy as Monotherapy
19/05/2025 -
Lifeward Names Mark Grant as New CEO
19/05/2025 -
Intelligent Bio Solutions Showcases Rapid, Non-Invasive Drug Testing Capabilities in Remote Queensland Workforce Deployment
19/05/2025
Pages